TxCell Investors
TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.
Investor Type:
Healthcare Company
Technology:
Advanced Longevity (R&D)
Founded Date:
2001
Industry:
Advanced and Next Generation Therapies (Various)
Employee Number:
51-100
Headquarters:
Valbonne, Provence-Alpes-Cote d'Azur, France